Prognosis of community acquired pneumonia (CAP): Value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response

Cytokine

Volumn 38, Issue 3, 2007, Pages 117-123

  Tejera, Alicia ^a   Santolaria, Francisco ^a   Diez, María Luisa ^a   Alemán Valls, María Remedios ^a   González Reimers, Emilio ^a   Martínez Riera, Antonio ^a   Milena Abril, Antonio ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Community acquired pneumonia (CAP); Cytokine; Pneumonia Severity Index (PSI); Prognosis; TREM 1

Indexed keywords

ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHEMOKINE RECEPTOR; CREATININE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 6; LACTATE DEHYDROGENASE; OXYGEN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELL 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ARTERIAL GAS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEHYDRATION; DIAGNOSTIC VALUE; DISEASE SEVERITY; DROWSINESS; FEMALE; GRIP STRENGTH; HAND GRIP; HUMAN; HYPOTENSION; INFLAMMATORY DISEASE; INFLAMMATORY INFILTRATE; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; OXYGEN TENSION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SEPSIS; TACHYPNEA; THORAX RADIOGRAPHY; UNIVARIATE ANALYSIS;

ACUTE-PHASE PROTEINS; AGED; AGED, 80 AND OVER; ANTIGENS, CD14; C-REACTIVE PROTEIN; CARRIER PROTEINS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PNEUMONIA; PROGNOSIS; RECEPTORS, IMMUNOLOGIC; TUMOR NECROSIS FACTOR-ALPHA;

FUNGI;

EID: 34547839766     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2007.05.002     Document Type: Article

References (37)

1. Fine M.J., Auble T.E., Yealy D.M., Hanusa B.H., Weissfeld L.A., Singer D.E., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336 (1997) 243-250
2. Fine M.J., Stone R.A., Singer D.E., Coley C.M., Marrie T.J., Lave J.R., et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Arch Intern Med 159 (1999) 970-980
3. Aujesky D., Auble T.E., Yealy D.M., Stone R.A., Obrosky D.S., Meehan T.P., et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 118 (2005) 384-392
4. Buising K.L., Thursky K.A., Black J.F., Macgregor L., Street A., Kennedy M., et al. Reconsidering what is meant by severe pneumonia: A prospective comparison of severity scores for community acquired pneumonia. Thorax 61 (2006) 419-424
5. Laterre P.F., Garber G., Levy H., Wunderink R., Kinasewitz G.T., Sollet J.P., et al. Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study. Crit Care Med 33 (2005) 952-961
6. Riquelme R., Torres A., el-Ebiary M., Mensa J., Estruch R., Ruiz M., et al. Community-acquired pneumonia in the elderly. Clinical and nutritional aspects. Am J Respir Crit Care Med 156 (1997) 1908-1914
7. Hedlund J. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short- and long-term prognosis. Scand J Infect Dis 97 suppl (1995) 1-60
8. Vecchiarino P., Bohannon R.W., Ferullo J., and Maljanian R. Short-term outcomes and their predictors for patients hospitalized with community-acquired pneumonia. Heart Lung 33 (2004) 301-307
9. Loeb M., and High K. The effect of malnutrition on risk and outcome of community-acquired pneumonia. Respir Care Clin N Am 11 (2005) 99-108
10. Masotti L., Ceccarelli E., Cappelli R., Barabesi L., Guerrini M., and Forconi S. Length of hospitalization in elderly patients with community-acquired pneumonia. Aging (Milano) 12 (2000) 35-41
11. Rodríguez-Gaspar M., Santolaria F., Jarque A., Gonzalez-Reimers E., Milena A., de la Vega M.J., et al. Prognostic value of cytokines in sirs general medical patients. Cytokine 15 (2001) 232-236
12. Selberg O., Hecker H., Martin M., Klos A., Bautsch W., and Kohl J. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 28 (2000) 2793-2798
13. Spittler A., Razenberger M., Kupper H., Kaul M., Hackl W., Boltz-Nitulescu G.H., et al. Relationship between Interleukin-6 plasma concentration in patients with sepsis, monocyte phenotype, monocyte phagocytic properties, and cytokine production. Clin Infect Dis 3 (2000) 1338-1342
14. Glynn P., Coakley R., Kilgallen I., Murphy N., and O'Neill S. Circulating interleukin 6 and interleukin 10 in community acquired pneumonia. Thorax 54 (1999) 51-55
15. Marik P.E. The clinical features of severe community-acquired pneumonia presenting as septic shock. Norasept II Study Investigators. J Crit Care 15 (2000) 85-90
16. Antunes G., Evans S.A., Lordan J.L., and Frew A.J. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity. Eur Respir J 20 (2002) 990-995
17. Kolsuz M., Erginel S., Alatas O., Alatas F., Metintas M., Ucgun I., et al. Acute phase reactants and cytokine levels in unilateral community-acquired pneumonia. Respiration 70 (2003) 615-622
18. Fernandez-Serrano S., Dorca J., Coromines M., Carratala J., Gudiol F., and Manresa F. Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia. Clin Diagn Lab Immunol 10 (2003) 813-820
19. Igonin A.A., Armstrong V.W., Shipkova M., Lazareva N.B., Kukes V.G., and Oellerich M. Circulating cytokines as markers of systemic inflammatory response in severe community-acquired pneumonia. Clin Biochem 37 (2004) 204-209
20. Gibot S., Cravoisy A., Levy B., Bene M.C., Faure G., and Bollaert P.E. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 350 (2004) 451-458
21. Determann R.M., Millo J.L., Gibot S., Korevaar J.C., Vroom M.B., van der Poll T., et al. Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia. Int Care Med 31 (2005) 1495-1500
22. Gibot S., Kolopp-Sarda M.N., Bene M.C., Cravoisy A., Levy B., Faure G.C., et al. Related articles, links plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 141 (2004) 9-15
23. Gibot S., Cravoisy A., Kolopp-Sarda M.N., Bene M.C., Faure G., Bollaert P.E., et al. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med 33 (2005) 792-796
24. Routsi C., Giamarellos-Bourboulis E.J., Antonopoulou A., Kollias S., Siasiakou S., Koronaios A., et al. Does soluble triggering receptor expressed on myeloid cells-1 play any role in the pathogenesis of septic shock?. Clin Exp Immunol 142 (2005) 62-67
25. Chao W.C., Wang C.H., Chan M.C., Chow K.C., Hsu J.Y., and Wu C.L. Predictive value of serial measurements of sTREM-1 in the treatment response of patients with community-acquired pneumonia. J Formos Med Assoc 106 (2007) 187-195
26. Blackburn G.L., Bistrian B.R., Maini B.S., Schlamm H.T., and Smith M.F. Nutritional and metabolic assessment of the hospitalized patient. JPEN 1 (1977) 11-22
27. González-Hermoso F., Porta R., and Herrero A. Resultados del estudio antropométrico de la población canaria adulta. Nutr Hosp 5 (1990) 238-247
28. Hernández-Plasencia D., Santolaria F., Hernández-García M., González Reimers E., Batista N., Jorge J., et al. Subjective Nutritional Assessment and short-term prognosis. J Nutr Med 2 (1991) 151-162
29. Tormo A., Santolaria F., González-Reimers E., Oramas J., Rodríguez Rodríguez E., Rodríguez Moreno F., et al. Short-term prognostic value of subjective nutritional assessment in general medical patients. J Nutr Med 4 (1994) 287-295
30. Bone R.C. Toward an epidemiology and natural history of SIRS. JAMA 268 (1992) 3452-3455
31. Charlson M., Szatrowski T.P., Peterson J., and Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 47 (1994) 1245-1251
32. Jennett B., and Teasdale G. Aspects of coma after severe head injury. Lancet 8017 (1977) 878-881
33. Marras T.K., Gutierrez C., and Chan C.K. Applying a prediction rule to identify low-risk patients with community-acquired pneumonia. Chest 118 (2000) 1339-1343
34. Dedier J., Singer D.E., Chang Y., Moore M., and Atlas S.J. Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals. Arch Intern Med 161 (2001) 2099-2104
35. Roson B., Carratala J., Dorca J., Casanova A., Manresa F., and Gudiol F. Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Clin Infect Dis 33 (2001) 158-165
36. Newman A.B., Kupelian V., Visser M., Simonsick E.M., Goodpaster B.H., Kritchevsky S.B., et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci 61 (2006) 72-77
37. Dremsizov T., Clermont G., Kellum J.A., Kalassian K.G., Fine M.J., and Angus D.C. Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course?. Chest 129 (2006) 968-978